- Home
- RLMD vs GIGM Comparison
RLMD vs GIGM Comparison
Compare RLMD & GIGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- GIGM
- Stock Information
- Founded
- RLMD 2004
- GIGM 1998
- Country
- RLMD United States
- GIGM Taiwan
- Employees
- RLMD N/A
- GIGM N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- GIGM Computer Software: Programming Data Processing
- Sector
- RLMD Health Care
- GIGM Technology
- Exchange
- RLMD Nasdaq
- GIGM Nasdaq
- Market Cap
- RLMD 22.0M
- GIGM 17.9M
- IPO Year
- RLMD N/A
- GIGM 2000
- Fundamental
- Price
- RLMD $0.61
- GIGM $1.43
- Analyst Decision
- RLMD Buy
- GIGM
- Analyst Count
- RLMD 3
- GIGM 0
- Target Price
- RLMD $5.00
- GIGM N/A
- AVG Volume (30 Days)
- RLMD 338.9K
- GIGM 14.9K
- Earning Date
- RLMD 08-06-2025
- GIGM 07-30-2025
- Dividend Yield
- RLMD N/A
- GIGM N/A
- EPS Growth
- RLMD N/A
- GIGM N/A
- EPS
- RLMD N/A
- GIGM N/A
- Revenue
- RLMD N/A
- GIGM $3,103,000.00
- Revenue This Year
- RLMD N/A
- GIGM N/A
- Revenue Next Year
- RLMD N/A
- GIGM N/A
- P/E Ratio
- RLMD N/A
- GIGM N/A
- Revenue Growth
- RLMD N/A
- GIGM N/A
- 52 Week Low
- RLMD $0.24
- GIGM $1.26
- 52 Week High
- RLMD $4.47
- GIGM $1.80
- Technical
- Relative Strength Index (RSI)
- RLMD 47.74
- GIGM 48.89
- Support Level
- RLMD $0.60
- GIGM $1.41
- Resistance Level
- RLMD $0.69
- GIGM $1.52
- Average True Range (ATR)
- RLMD 0.07
- GIGM 0.04
- MACD
- RLMD -0.01
- GIGM 0.01
- Stochastic Oscillator
- RLMD 41.86
- GIGM 40.60
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About GIGM GigaMedia Limited
GigaMedia Ltd is a publisher of online games. It has only one reportable segment, Digital Entertainment service. Digital Entertainment service business operates a portfolio of online games, mainly targeting online game players across Europe, and Asia, including Greater China and Southeast Asia. The company's portfolio of online games includes predominantly PC-based, non-cash gambling, or casino casual games, including MahJong and various card and table games. The company's product lines include MahJong, AkaSeka, Yume 100, Fun Vegas, and others. The company operates in Taiwan and Hong Kong.